• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.在一家联邦合格健康中心进行乳腺癌基因风险评估的可行性研究。
Cancer. 2018 Sep 15;124(18):3733-3741. doi: 10.1002/cncr.31635. Epub 2018 Oct 15.
2
Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?乳腺癌或卵巢癌的诊断是否会引发遗传咨询转诊?
Int J Gynecol Cancer. 2013 Mar;23(3):431-6. doi: 10.1097/IGC.0b013e318280f2b4.
3
Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.在一个有家族病史且符合 2005 年 USPSTF 推荐进行 BRCA 基因咨询转诊标准的大型医疗体系中,具有家族病史的女性的流行情况和医疗保健措施。
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):728-35. doi: 10.1158/1055-9965.EPI-12-1280. Epub 2013 Jan 31.
4
Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.乳腺癌女性转诊至遗传学专业人员的国家综合癌症网络指南的遵循模式。
Am J Clin Oncol. 2016 Aug;39(4):363-7. doi: 10.1097/COC.0000000000000073.
5
Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.在一项随机对照试验中识别干预效果的中介因素,以激励乳腺癌和卵巢癌幸存者进行癌症遗传风险评估。
Ann Behav Med. 2023 Oct 16;57(11):965-977. doi: 10.1093/abm/kaad048.
6
Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.将遗传咨询师嵌入肿瘤诊所可提高卵巢癌女性的检测率和及时性。
Gynecol Oncol. 2021 Feb;160(2):457-463. doi: 10.1016/j.ygyno.2020.11.003. Epub 2020 Nov 21.
7
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
8
Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.年轻女性在常规初级保健中接受遗传性乳腺癌和卵巢癌风险筛查的观点。
Womens Health Issues. 2024 May-Jun;34(3):268-275. doi: 10.1016/j.whi.2024.01.004. Epub 2024 Mar 5.
9
Assessment of and Interventions for Women at High Risk for Breast or Ovarian Cancer: A Survey of Primary Care Physicians.高危乳腺癌或卵巢癌女性的评估和干预:一项初级保健医生调查。
Cancer Prev Res (Phila). 2021 Feb;14(2):205-214. doi: 10.1158/1940-6207.CAPR-20-0407. Epub 2020 Oct 6.
10
Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.简化加利福尼亚北部医疗体系中卵巢癌女性的基因检测。
Gynecol Oncol. 2020 Oct;159(1):221-228. doi: 10.1016/j.ygyno.2020.07.027. Epub 2020 Aug 7.

引用本文的文献

1
Interventions to improve access to cancer care in underserved populations in high income countries: a systematic review.改善高收入国家医疗服务不足人群癌症护理可及性的干预措施:一项系统评价
Oncol Rev. 2024 Nov 5;18:1427441. doi: 10.3389/or.2024.1427441. eCollection 2024.
2
Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial.基于聊天机器人的癌症遗传服务与标准护理传递模式的利用率:BRIDGE 随机临床试验。
JAMA Netw Open. 2024 Sep 3;7(9):e2432143. doi: 10.1001/jamanetworkopen.2024.32143.
3
Risk-Stratified Breast Cancer Screening in Malaysia: Challenges and Opportunities.马来西亚风险分层乳腺癌筛查:挑战与机遇。
Asian Pac J Cancer Prev. 2024 Mar 1;25(3):785-791. doi: 10.31557/APJCP.2024.25.3.785.
4
Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.年轻女性在常规初级保健中接受遗传性乳腺癌和卵巢癌风险筛查的观点。
Womens Health Issues. 2024 May-Jun;34(3):268-275. doi: 10.1016/j.whi.2024.01.004. Epub 2024 Mar 5.
5
Innovating for a Just and Equitable Future in Genomic and Precision Medicine Research.为基因组与精准医学研究的公正平等未来而创新。
Am J Bioeth. 2023 Jul;23(7):1-4. doi: 10.1080/15265161.2023.2215201.
6
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening.初级保健中的主动乳腺癌风险评估:基于筛查原则的综述。
Br J Cancer. 2023 May;128(9):1636-1646. doi: 10.1038/s41416-023-02145-w. Epub 2023 Feb 3.
7
Usability Testing of an Interoperable Computerized Clinical Decision Support Tool for Fall Risk Management in Primary Care.可互操作的计算机临床决策支持工具用于初级保健中跌倒风险管理的可用性测试。
Appl Clin Inform. 2023 Mar;14(2):212-226. doi: 10.1055/a-2006-4936. Epub 2023 Jan 4.
8
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.患者和临床医生决策支持以增加初级保健中遗传性乳腺癌和卵巢癌综合征的遗传咨询:一项集群随机临床试验。
JAMA Netw Open. 2022 Jul 1;5(7):e2222092. doi: 10.1001/jamanetworkopen.2022.22092.
9
Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.促进乳腺癌风险遗传咨询的文化敏感干预的初步研究。
BMC Health Serv Res. 2022 Jun 25;22(1):826. doi: 10.1186/s12913-022-08193-x.
10
Healthcare Predictors of Information Dissemination About Genetic Risks.遗传风险信息传播的医疗保健预测因素。
Cancer Control. 2022 Jan-Dec;29:10732748221104666. doi: 10.1177/10732748221104666.

本文引用的文献

1
Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.基于人群的年轻乳腺癌幸存者样本中BRCA检测与癌症风险管理的种族差异。
Cancer. 2017 Jul 1;123(13):2497-2505. doi: 10.1002/cncr.30621. Epub 2017 Feb 9.
2
Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.美国 2017 年癌症筛查:对当前美国癌症协会指南和癌症筛查当前问题的回顾。
CA Cancer J Clin. 2017 Mar;67(2):100-121. doi: 10.3322/caac.21392. Epub 2017 Feb 7.
3
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.医疗保健隔离、医生建议与乳腺癌女性BRCA1/2检测中的种族差异
J Clin Oncol. 2016 Aug 1;34(22):2610-8. doi: 10.1200/JCO.2015.66.0019. Epub 2016 May 9.
4
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.乳腺癌统计数据,2015:黑人和白人女性发病率趋同。
CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29.
5
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.平均风险女性的乳腺癌筛查:美国癌症协会2015年指南更新
JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783.
6
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.多基因panel 检测在遗传性乳腺癌和卵巢癌风险评估中的临床可操作性。
JAMA Oncol. 2015 Oct;1(7):943-51. doi: 10.1001/jamaoncol.2015.2690.
7
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.使用 25 基因组合新一代测序对乳腺癌患者进行 BRCA1 和 BRCA2 检测时个体突变的频率。
Cancer. 2015 Jan 1;121(1):25-33. doi: 10.1002/cncr.29010. Epub 2014 Sep 3.
8
Assessing and managing breast cancer risk: clinicians' current practice and future needs.评估与管理乳腺癌风险:临床医生的当前实践与未来需求
Breast. 2014 Oct;23(5):644-50. doi: 10.1016/j.breast.2014.06.014. Epub 2014 Jul 4.
9
Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.大型综合医疗系统中女性患者的遗传咨询转诊及BRCA1/2检测相关特征。
Genet Med. 2015 Jan;17(1):43-50. doi: 10.1038/gim.2014.68. Epub 2014 Jun 19.
10
A randomized, controlled trial to increase discussion of breast cancer in primary care.一项旨在增加基层医疗中乳腺癌讨论的随机对照试验。
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1245-53. doi: 10.1158/1055-9965.EPI-13-1380. Epub 2014 Apr 24.

在一家联邦合格健康中心进行乳腺癌基因风险评估的可行性研究。

A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.

机构信息

Section of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, Illinois.

Institute for Health Research and Policy, School of Public Health, University of Illinois at Chicago, Chicago, Illinois.

出版信息

Cancer. 2018 Sep 15;124(18):3733-3741. doi: 10.1002/cncr.31635. Epub 2018 Oct 15.

DOI:10.1002/cncr.31635
PMID:30320429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6214782/
Abstract

BACKGROUND

The US Preventive Services Task Force (USPSTF) endorses routine screening for genetic risk of breast and/or ovarian cancer as a component of primary health care. Implementation of this recommendation may prove challenging, especially in clinics serving disadvantaged communities.

METHODS

The authors tested the feasibility of implementing the USPSTF mandate at a federally qualified health center (FQHC) to identify women who were eligible for genetic counseling (GC). A 12-month usual-care phase was followed by a 12-month intervention phase, during which time cancer genetic risk assessment (CGRA) was systematically performed for all women aged 25 to 69 years who presented for an annual examination. Women who were eligible for GC were recruited to participate in the study.

RESULTS

After initiating CGRA, 112 women who were eligible for GC consented to study participation, and 56% of them received a referral for GC from their primary care physician. A subgroup of 50 participants were seen by the same primary care physician during both the usual-care and intervention phases. None of these patients was referred for GC during usual care, compared with 64% after the initiation of CGRA (P < .001). Only 16% of referred participants attended a GC session.

CONCLUSIONS

Implementing USPSTF recommendations for CGRA as a standard component of primary health care in FQHCs is feasible and improves referral of minority women for GC, but more work is needed to understand the beliefs and barriers that prevent many underserved women from accessing cancer genetic services.

摘要

背景

美国预防服务工作组(USPSTF)支持将乳腺癌和/或卵巢癌遗传风险的常规筛查作为初级保健的一个组成部分。实施这一建议可能具有挑战性,尤其是在为弱势社区服务的诊所中。

方法

作者在一家合格的联邦健康中心(FQHC)测试了实施 USPSTF 授权以识别有资格接受遗传咨询(GC)的女性的可行性。在进行了为期 12 个月的常规护理阶段后,进行了为期 12 个月的干预阶段,在此期间,对所有年龄在 25 至 69 岁之间前来进行年度检查的女性进行了癌症遗传风险评估(CGRA)。有资格接受 GC 的女性被招募参加研究。

结果

在开始 CGRA 后,有 112 名有资格接受 GC 的女性同意参与研究,其中 56%的人从他们的初级保健医生那里获得了 GC 的转介。50 名参与者的一个亚组在常规护理和干预阶段都由同一位初级保健医生就诊。与 CGRA 启动后的 64%相比,这些患者中没有一人在常规护理期间被转介接受 GC(P < 0.001)。只有 16%的被转介者参加了 GC 会议。

结论

在 FQHC 中将 USPSTF 关于 CGRA 的建议作为初级保健的标准组成部分实施是可行的,可以增加少数族裔女性接受 GC 的转介,但需要进一步研究来了解阻止许多服务不足的女性获得癌症遗传服务的信念和障碍。